Table 5.
Mammograms per woman | Breast cancer deaths per 100,000 women | Rate ratio BC deaths | Breast cancer ** mortality reduction | ||
---|---|---|---|---|---|
intervention group | control group | ||||
Age trial | 4.84 | 16 | 21 | 0.75 | 25% (3 to 42%) * |
Model average | 5.23 | 19 | 23 | 0.85 | 15.3% [range 13ā17%] |
Model D | 5.30 | 17 | 20 | 0.83 | 17.0% |
Model E | 4.90 | 20 | 25 | 0.83 | 16.9% |
Model M | 5.43 | 20 | 23 | 0.86 | 13.6% |
Model S | 5.29 | 22 | 25 | 0.87 | 13.2% |
Model W | 5.23 | 19 | 22 | 0.84 | 16.0% |
95% confidence interval in parentheses
The Age trial measured the effect of annual screening of women aged 40 to 49 on breast cancer mortality. Therefore, the trial and the simulation models excluded breast cancer deaths that occurred in women diagnosed with breast cancer before age 40 and after age 49.